Target intelligence / Profile preview

Intracellular pH modulation

Molecular classification
Other (aggregate cellular process), Acid-base transporters (including Na+/H+ exchanger, Na+/HCO3− cotransporter, Cl−/HCO3− anion exchanger, vacuolar-ATPase, etc.), Buffer systems (protein buffers, phosphate buffers)
01

Overview

Intracellular pH modulation refers to the tightly controlled regulation of the pH within cells, which is essential for normal cellular function, affecting protein ionization, membrane transport, cell proliferation, differentiation, apoptosis, and metabolic activity. This process is achieved via a concerted network of transmembrane ion transporters (such as Na+/H+ exchangers, Na+/HCO3− cotransporters, Cl−/HCO3− exchangers, vacuolar-ATPase), together with intracellular buffer systems. Aberrations in intracellular pH homeostasis are implicated in various diseases, including cancer. However, "intracellular pH modulation" does not refer to a unique druggable molecule or receptor, but rather an emergent property resulting from the actions of multiple proteins and buffering agents. Because "intracellular pH modulation" is a process rather than a canonical molecular target, this entry is incorrect for most applications requiring a well-defined protein, receptor, enzyme, or transporter. For structured drug discovery or mechanistic databases, it is essential to specify individual pH-regulating molecules, such as "Na+/H+ exchanger 1 (NHE1)", "Vacuolar-type H+-ATPase (V-ATPase)", or "Cl−/HCO3− anion exchanger (AE1)", which are genuine drug targets.

Other names
Intracellular pH regulationpHi modulationpHi control
02

Mechanism of action

Inhibition of proton transporters or exchangers. Disruption of acid/base balance via membrane transport inhibition. Modulation of buffering capacity.

03

Biological functions

Cell proliferationApoptosisDifferentiationSignal transductionCell cycle progressionMaintenance of cellular homeostasis
04

Disease associations

Cancer (altered pH regulation implicated in tumor growth, survival, and metastasis)Other (many diseases involve perturbations of pHi but not via a discrete druggable target)
05

Safety considerations

Systemic or off-target disruption of acid-base homeostasisCellular toxicity due to inappropriate pHi modulationLack of specificity: targeting pHi affects many cell types and functions
06

Interacting drugs

Amiloride and its derivatives (Na+/H+ exchanger inhibitors)

2 more in the full profile.

07

Biomarkers

Intracellular pH measurement (e.g., BCECF fluorescence dye)Expression/activity of specific pH-regulating transporters (e.g., Na+/H+ exchanger–NHE1, V-ATPase)

Beyond the preview

Go deeper on Intracellular pH modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intracellular pH modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call